O1–06–02: Effect of bapineuzumab on CSF p‐tau and t‐tau in mild‐to‐moderate Alzheimer's disease: Results from two phase III trials in APOE‐ε4 carriers and noncarriers. (1st July 2013) - Streffer, Johannes; Blennow, Kaj; Salloway, Stephen; Zetterberg, Henrik; Xu, Yi‐Zheng; Lu, Yuan; Lull, Julia; Collins, Peter; Tudor, Iulia Cristina; Gregg, Keith; Styren, Scot; Yuen, Eric; et al.